CAI
CAI
US1421521071
Caris Life Sciences, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
8.39B EUR
5.04B EUR
5.05B EUR
7.62B EUR
Enterprise Value
7.43B EUR
4.8B EUR
4.66B EUR
7.25B EUR
Valuation Multiples
Trailing P/E
17.57x
47.9x
148.72x
220.99x
Forward P/E
80.46x
--
--
--
Price to Sales
8.48x
5.09x
5.57x
11.03x
Price to Book
14.18x
8.51x
8.52x
13.2x
EV/Revenue
7.51x
4.85x
5.14x
10.5x
EV/EBITDA
42.7x
23.75x
30.84x
54.14x
Price to FCF (P/FCF)
132.67x
40.62x
40.94x
75.53x
EV/FCF
117.46x
38.7x
37.78x
71.88x
FCF Yield
0.75%
2.46%
2.44%
1.32%
ende